All Viruses articles – Page 6
-
NewsResearch identifies key antibodies for development of broadly protective norovirus vaccine
A new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies.
-
NewsNew antibodies show potential to defeat all SARS-CoV-2 variants
Researchers discovered that a paired combination of antibodies binding to the two domains of the SARS-CoV-2 viral particle showed promising results in elimination of all virus variants caused in the COVID-19 pandemic.
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsHidden dangers and myths: What you need to know about HPV and cancer
While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that the majority of people are unaware that ...
-
NewsNew biosensor can detect airborne bird flu in under 5 minutes
A new biosensor for monitoring aerosol particles of H5N1 works within five minutes, preserving the sample of the microbes for further analysis and providing a range of the pathogen concentration levels detected on a farm.
-
NewsA surprising link between Crohn’s disease and the Epstein-Barr virus
A longitudinal study has revealed strong and surprising evidence showing that exposure to Epstein-Barr virus (EBV) can lead to a higher risk of Crohn’s disease. Researchers are now trying to find out the mechanistic actions in their associations.
-
NewsStudy: Smartwatches could end the next pandemic
Everyday smartwatches are extremely accurate in detecting viral infection long before symptoms appear — new research shows how they could help stop a pandemic before it even begins.
-
NewsNew COVID-flu vaccine platform could provide broad, lasting protection
Researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains.
-
NewsRecommendations announced for influenza vaccine composition for the 2025-2026 northern hemisphere influenza season
The World Health Organization (WHO) has announced the recommendations for the viral composition of influenza vaccines for the 2025-2026 influenza season in the northern hemisphere.
-
NewsCambridge initiative to address risks of future engineered pandemics
Management strategies are initiated by University of Cambridge to address the challenges and preventive measures required in response to a potential engineered pandemic threat in the future.
-
NewsNew test identifies prior infection by zika virus and all four dengue virus serotypes
An alternative approach is developed to detect and distinguish between antibodies induced by the dengue and zika virus in blood samples. The strategy can be used to orient public health policy and evaluate the efficacy of dengue vaccines.
-
NewsCold sore discovery IDs unknown trigger for those annoying flare-ups
Scientists have a new target to prevent cold sores after researchers discovered an unexpected way that the herpes virus re-activates in the body. The finding could also have important implications for genital herpes caused by the same virus.
-
NewsFrom dormant to danger: How VZV reactivation is driving CNS infections
Researchers conducted a comprehensive study spanning 10 years (2013–2022), to identify the VZV-related infections affecting the central nervous system. Their study reveals a marked increase in adult VZV-related CNS infections, particularly since 2019.
-
NewsStudy compares indoor transmission-risk metrics for infectious diseases
A recent study delves into the complex world of assessing the transmission risk of infectious diseases in indoor spaces. Understanding how to accurately evaluate the effectiveness of non-pharmaceutical interventions (NPIs) has become crucial.
-
NewsInterventions could eliminate transmission of hepatitis B from mothers to babies in Africa
Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps needed to combat the vertical transmission of chronic hepatitis B virus (HBV) in Africa. Source: Solasly A baby in the womb of its mother being held by its mother and ...
-
NewsFlu vaccine offers moderate protection against strains dominant in most European countries in 2024/2025
According to interim analysis of influenza vaccine effectiveness for the 2024/2025 season in Europe, the vaccine offered moderate protection against dominant influenza A strains, and strong protection against influenza B.
-
NewsExperts recommend mAb protection against RSV as standard care for all infants
While RSV poses a serious threat to the health of infants and young children, prophylactic mAbs offer safe and effective protection for an entire season, according to international health organizations.
-
NewsNewly launched Enodia Therapeutics is a biotech company with a new approach for targeted protein degradation
Argobio and the Institut Pasteur have announced the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for treating cancer, inflammatory diseases and viral infections.
-
NewsImmunity against seasonal H1N1 flu reduces bird flu severity in ferrets, study suggests
Pre-existing immunity against seasonal H1N1 flu might help explain why most reported human cases of H5N1 bird flu in the U.S. have not resulted in lethal outcomes, suggests a new study.
-
NewsNew 3D imaging approach reveals intricate steps of virus assembly
A new integrated 3D imaging approach combines cryo-light microscopy and cryo-soft X-ray tomography to reveal the intricate ultrastructure of herpes simplex virus-1 (HSV-1) assembly.